(Q43184359)

English

Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer

scientific article published on 25 January 2010

Statements

Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer (English)
Shirin Khambata-Ford
Christopher T Harbison
Lowell L Hart
Melissa Awad
Li-An Xu
Christine E Horak
Shaker Dakhil
Robert C Hermann
Thomas J Lynch
Martin R Weber
25 January 2010
918-927

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit